José Antonio Possatto Ferrer

6PUBLICATIONS
13CO-AUTHORS
Major global burdens of diseaseSolid tumoursEpidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 09, 2026
APACHE II, SOFA, and SAPS III after transhiatal and thoracoscopic in prone position esophagectomy for esophageal cancer: a single-center retrospective cohort analysis.

José Antonio Possatto Ferrer, Valdir Tercioti Junior, Antonio Luis Eiras Falcão

|Oct 18, 2023
GASTRIC NEUROENDOCRINE TUMOR: WHEN SURGICAL TREATMENT IS INDICATED?

Ademar Caetano Assis Filho, Valdir Tercioti Junior, Nelson Adami Andreollo

|Jan 11, 2023
ESOPHAGOCELE DUE TO TWO TIMES CAUSTIC INGESTIONS: RESECTION THROUGH VIDEOTHORACOSCOPY.

Iuri Pedreira Filardi Alves, Valdir Tercioti Junior, João de Souza Coelho Neto

|Jun 29, 2022
THE ESOPHAGEAL, GASTRIC, AND COLORECTAL TUMORS AND THE ESOPHAGOGASTRODUODENOSCOPIES AND COLONOSCOPIES BY THE BRAZILIAN UNIFIED HEALTH SYSTEM: WHAT IS THE IMPORTANCE?

Marilisa Ferruda Andreoli Risso, Luigi Carlo da Silva Costa, Valdir Tercioti

|Jan 12, 2022
NEOADJUVANT CHEMORADIOTHERAPY FOLLOWED BY TRANSHITAL ESOPHAGECTOMY IN LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA: IMPACT OF PATHOLOGICAL COMPLETE RESPONSE.

Iuri Pedreira Fillardi Alves, Valdir Tercioti Junior, João de Souza Coelho Neto

|Dec 21, 2019
ADJUVANT CHEMORADIOTHERAPY AFTER SUBTOTAL OR TOTAL GASTRECTOMY AND D2 LIMPHADENECTOMY INCREASES SURVIVAL IN ADVANCED GASTRIC CANCER?

Nelson Adami Andreollo, Eric Drizlionoks, Valdir Tercioti-Junior

Pageof 1